Cargando…
Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a Syrian hamster orthotopic pancreatic cancer model
BACKGROUND: The limited efficacy of current treatments against pancreatic cancer has prompted the search of new alternatives such as virotherapy. Activation of the immune response against cancer cells is emerging as one of the main mechanisms of action of oncolytic viruses (OV). Direct oncolysis rel...
Autores principales: | Nistal-Villan, Estanislao, Bunuales, Maria, Poutou, Joanna, Gonzalez-Aparicio, Manuela, Bravo-Perez, Carlos, Quetglas, Jose I., Carte, Beatriz, Gonzalez-Aseguinolaza, Gloria, Prieto, Jesus, Larrea, Esther, Hernandez-Alcoceba, Ruben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681018/ https://www.ncbi.nlm.nih.gov/pubmed/26671477 http://dx.doi.org/10.1186/s12943-015-0479-x |
Ejemplares similares
-
A Versatile Vector for In Vivo Monitoring of Type I Interferon Induction and Signaling
por: Nistal-Villan, Estanislao, et al.
Publicado: (2016) -
Oncolytic Virotherapy in Glioma Tumors
por: Rius-Rocabert, Sergio, et al.
Publicado: (2020) -
Interferon alpha bioactivity critically depends on Scavenger receptor class B type I function
por: Vasquez, Marcos, et al.
Publicado: (2016) -
The effects of radiation on antitumor efficacy of an oncolytic adenovirus vector in the Syrian hamster model
por: Young, Brittany A., et al.
Publicado: (2013) -
Targeting Signaling Pathway Downstream of RIG-I/MAVS in the CNS Stimulates Production of Endogenous Type I IFN and Suppresses EAE
por: Kronborg Hansen, Anne K., et al.
Publicado: (2022)